136 related articles for article (PubMed ID: 11012743)
21. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
Thiele J; Kvasnicka HM; Niederle N; Kloke O; Schmidt M; Lienhard H; Zirbes T; Meuter RB; Leder LD; Fischer R
Am J Hematol; 1995 Sep; 50(1):30-9. PubMed ID: 7545352
[TBL] [Abstract][Full Text] [Related]
22. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
23. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
[TBL] [Abstract][Full Text] [Related]
24. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon.
Facchetti F; Tironi A; Marocolo D; Capucci A; Ruggeri G; Bellotti D; Rossi G
Histopathology; 1997 Jul; 31(1):3-11. PubMed ID: 9253618
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow trephine biopsy findings in chronic myeloid leukemia.
Khonglah Y; Basu D; Dutta TK
Malays J Pathol; 2002 Jun; 24(1):37-43. PubMed ID: 16329554
[TBL] [Abstract][Full Text] [Related]
26. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Schmitt-Gräff A; Hülsemann R; Diehl V
Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
[TBL] [Abstract][Full Text] [Related]
27. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
28. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
Thiele J; Wienhold S; Zankovich R; Fischer R
Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
[TBL] [Abstract][Full Text] [Related]
29. Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Berger U; Engelich G; Maywald O; Pfirrmann M; Hochhaus A; Reiter A; Metzgeroth G; Gnad U; Hasford J; Heinze B; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Hehlmann R;
Leukemia; 2003 Sep; 17(9):1820-6. PubMed ID: 12970782
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
Chim CS; Ma SK; Lam CK
Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
[TBL] [Abstract][Full Text] [Related]
31. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetics of chronic myelogenous leukemia (CML) correlated to the histopathology of bone marrow biopsies.
Werner M; Kaloutsi V; Buhr T; Delventhal S; Vykoupil KF; Georgii A
Ann Hematol; 1991 Oct; 63(4):201-5. PubMed ID: 1932298
[TBL] [Abstract][Full Text] [Related]
33. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML.
Thiele J; Kvasnicka HM; Zirbes TK; Baldus SE; Djuren O; Lienhard H; Lorenzen J; Leder LD; Niederle N; Fischer R
Hematopathol Mol Hematol; 1996; 10(4):201-12. PubMed ID: 9042663
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
Histopathology; 2003 Nov; 43(5):470-9. PubMed ID: 14636273
[TBL] [Abstract][Full Text] [Related]
35. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases].
Nafe R; Holgado de Colombo S; Choritz H; Georgii A
Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
[TBL] [Abstract][Full Text] [Related]
37. The histopathology of chronic myeloproliferative diseases.
Georgii A; Buesche G; Kreft A
Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
[TBL] [Abstract][Full Text] [Related]
39. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
40. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
